Array-based pharmacogenomics of molecular-targeted therapies in oncology.
Sanoudou, D
Array-based pharmacogenomics of molecular-targeted therapies in oncology. [electronic resource] - The pharmacogenomics journal Jun 2012 - 185-96 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1473-1150
10.1038/tpj.2011.53 doi
Animals
Antineoplastic Agents--therapeutic use
Drug Resistance, Neoplasm
Economics, Pharmaceutical
ErbB Receptors--antagonists & inhibitors
Gene Expression Profiling--methods
Genetic Testing
Humans
Molecular Targeted Therapy
Neoplasms--drug therapy
Oligonucleotide Array Sequence Analysis
Patient Selection
Precision Medicine
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins c-kit--antagonists & inhibitors
Receptor, ErbB-2--antagonists & inhibitors
Signal Transduction--drug effects
Treatment Outcome
Array-based pharmacogenomics of molecular-targeted therapies in oncology. [electronic resource] - The pharmacogenomics journal Jun 2012 - 185-96 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1473-1150
10.1038/tpj.2011.53 doi
Animals
Antineoplastic Agents--therapeutic use
Drug Resistance, Neoplasm
Economics, Pharmaceutical
ErbB Receptors--antagonists & inhibitors
Gene Expression Profiling--methods
Genetic Testing
Humans
Molecular Targeted Therapy
Neoplasms--drug therapy
Oligonucleotide Array Sequence Analysis
Patient Selection
Precision Medicine
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins c-kit--antagonists & inhibitors
Receptor, ErbB-2--antagonists & inhibitors
Signal Transduction--drug effects
Treatment Outcome